BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• DTRA Commits Additional Funds to MeMed’s Innovative Bacterial Versus Viral Test and Point-of-Care Platform

  MeMed today announced DTRA’s expanded commitment to their point-of-care immunoassay platform and ground breaking bacterial versus viral host-response test.

  December 5, 2018

   · 

  3 min read
• Policy

  OneOme Receives License to Offer its Comprehensive Pharmacogenomic Test in New York State

  OneOme’s RightMed® comprehensive test is now offered in all 50 states

  December 5, 2018

   · 

  2 min read
• Business

  PAREXEL Collaborates with Eli Lilly and Company to Develop China’s Clinical Research Workforce

  The program will bring high-value training opportunities to China’s clinical trial sites and investigators, enhancing the execution of local clinical trials and driving innovation in China’s biopharmaceutical industry.

  December 5, 2018

   · 

  4 min read
• Business

  Houston Medical Imaging Announces a New Outpatient Imaging Center in Pearland, Texas

  Center of Excellence to Deliver Compassionate Care at a New and Convenient Location

  December 5, 2018

   · 

  1 min read
• FDA

  Luma Therapeutics Announces Launch of the Illuvinate System, a New In-Home Treatment for Plaque Psoriasis

  FDA-Cleared Treatment is Based on Proven Techniques and Designed for Lasting Remission

  December 5, 2018

   · 

  5 min read
• Job Trends

  It’s Of-fish-ial -- USANA Earns Seal of Approval for Omega-3 Supplement

  BiOmega™ Passes Rigorous Testing by ConsumerLab.com

  December 5, 2018

   · 

  2 min read
• Business

  uBiome Announces First Stage of CDx Development in Collaboration w/ Puma Biotechnology

  Today announced the first stage of companion diagnostic development with Puma Biotechnology to investigate the role of the microbiome in adverse events related to neratinib treatment of patients with HER2-positive breast cancer.

  December 5, 2018

   · 

  2 min read
• Biotech Beach

  Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference on December 5, 2018

  Edwards Lifesciences Corporation will discuss the company’s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today in Irvine, California.

  December 5, 2018

   · 

  11 min read
• Deals

  SOL Global Investments CEO Issues Statement on Sale of Latin American Assets

  SOL Global Investments Corp. today makes a statement on the September 27, 2018 sale of it’s Latin America operations, LATAM Holdings Inc., to Aphria Inc.

  December 5, 2018

   · 

  6 min read
• Drug Development

  Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome

  Clinical-regulatory pathway defined following recent meetings with regulatory authorities

  December 5, 2018

   · 

  7 min read